Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;33(4):190-8.
doi: 10.1002/clc.20681.

Should we measure C-reactive protein on earth or just on JUPITER?

Ambareesh Bajpai  1 , Abhinav Goyal, Laurence Sperling
Affiliations
Review

Should we measure C-reactive protein on earth or just on JUPITER?

Ambareesh Bajpai et al. Clin Cardiol. 2010 Apr.

Abstract

Evidence for the role of inflammation in the pathogenesis of atherosclerosis is compelling and has generated interest in high-sensitivity C-reactive protein (hs-CRP) as a marker of cardiovascular risk. Data regarding hs-CRP and cardiovascular risk, though largely consistent, is of unclear clinical relevance. Most recently, the Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial has led to further debate regarding the utility of hs-CRP. This article provides a comprehensive review of the data regarding cardiovascular risk and hs-CRP with an emphasis on the JUPITER trial and concludes with an evidence-based analysis of the current role of hs-CRP in cardiovascular risk assessment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C‐reactive protein. N Engl J Med 2008; 359(21): 2195–2207. - PubMed
    1. Greenland P, Smith SC Jr, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001; 104(15): 1863–1867. - PubMed
    1. Kushner I. C‐reactive protein and the acute‐phase response. Hosp Pract (Off Ed) 1990; 25(3A): 13,16,21–8. - PubMed
    1. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C‐reactive protein in health and disease. J Clin Invest 1993; 91(4): 1351–1357. - PMC - PubMed
    1. Chang MK, Binder CJ, Torzewski M, et al. C‐reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 2002; 99(20): 13043–13048. - PMC - PubMed

MeSH terms